Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily insulin detemir timed to individual need versus bedtime insulin glargine in type 2 diabetes with asymmetric day-night insulin requirement
2006-002047-92Phase 4Completed
- Sponsor
- Newcastle Primary Care Trust
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Insulin detemir with Insulin glargine (2 arms). Primary endpoint: Responder rate based on pre-breakfast and pre-dinner plasma glucose without hypoglycaemia. Started Jan 2007; status: completed.
02
Drugs
insulin detemirinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002047-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002047-92.